Back to results
US 2025/0051470 A1Published application
Methods of treating graft versus host disease
OwnerAntonio Francesco DI NAROinventor
Life of this patent
Estimating the term…
Abstract
This disclosure relates to methods of using an anti-CD26 antibody and antigen binding fragments thereof for the treat-ment of graft versus host disease.
Claims13
A method of treating graft-versus-host disease (GvHD) in a subject, comprising administering a therapeutically effective amount of an anti-CD26 antibody to the subject, wherein the antibody is administered at a dose of between 4.0 mg/m2/day and 25.0 mg/m2/day, and wherein the antibody is administered once daily for five days followed by administration every other day for a total of 16 doses.
Dependencies are inferred from the claim text.